Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Dec;7(Suppl 6):S758-S759.
doi: 10.21037/tau.2018.08.07.

The timing of radical cystectomy following neoadjuvant chemotherapy

Venkat M Ramakrishnan  1 , Jairam R Eswara  1
Affiliations
Editorial

The timing of radical cystectomy following neoadjuvant chemotherapy

Venkat M Ramakrishnan et al. Transl Androl Urol. 2018 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Yafi FA, Kassouf W. Radical cystectomy is the treatment of choice for invasive bladder cancer. Can Urol Assoc J 2009;3:409-12. 10.5489/cuaj.1156 - DOI - PMC - PubMed
    1. Tabayoyong W, Li R, Gao J, et al. Optimal timing of chemotherapy and surgery in patients with muscle-invasive bladder cancer and upper urinary tract urothelial carcinoma. Urol Clin North Am 2018;45:155-67. 10.1016/j.ucl.2017.12.002 - DOI - PubMed
    1. Mmeje C, Benson C, Nogueras-González G, et al. Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy. BJU Int 2018;122:89-98. 10.1111/bju.14211 - DOI - PubMed
    1. Parekh DJ, Reis IM, Castle EP, et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 2018;391:2525-36. 10.1016/S0140-6736(18)30996-6 - DOI - PubMed